Back to Journals » Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
Editor-in-Chief: Professor Garry Walsh
ISSN 1176-6336 (Print) - went to online only in 2009
An international, peer-reviewed open access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (2611)
- Volume 22, 2026 (55)
- Volume 21, 2025 (162)
- Volume 20, 2024 (86)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Latest articles:
- 5 records -
The Future of Interventional Keratoconus Management: Perspectives on Integrating Epithelium-on Oxygen-Enriched Cross-Linking into Comprehensive Care Pathways
Beckman KA, Syed ZA, Gromacki SJ
Therapeutics and Clinical Risk Management 2026, 22:580025
Published Date: 5 June 2026
Transcranial Magnetic Stimulation Combined with Speech-Language Therapy for Post-Stroke Aphasia Recovery: A Systematic Review and Network Meta-Analysis
Lin J, Bao Y, Fang M, Zhang H
Therapeutics and Clinical Risk Management 2026, 22:597978
Published Date: 5 June 2026
Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control Study
Amirthalingam P, Alarawi FA, Jassas Alagwar LM, Alatawi MS, Saeed Alfahmi Alzahrani MS, A Albalwi AO, Alrashidi A, Elsaid Hamdan AM, Fahad Alqifari S, Alshareef H, Aljabri A, Sirag N, Pakkir Mohamed SH, Ali MAS
Therapeutics and Clinical Risk Management 2026, 22:610579
Published Date: 4 June 2026
Extracellular Vesicle-Based Strategies for the Prevention of Chemotherapy-Induced Cardiotoxicity
Shen Z, Qiu J, Yu W, Chen R, Jiang Y
Therapeutics and Clinical Risk Management 2026, 22:597871
Published Date: 3 June 2026
Association Between Insulin Regimen and Cardiovascular Risk in Indonesian Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
Natsir RM, Halimah E, Diantini A, Levita J
Therapeutics and Clinical Risk Management 2026, 22:611165
Published Date: 3 June 2026